Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Urologicals
    • 1.2.1.2 Hormonal Therapy
    • 1.2.1.3 Gynecological
    • 1.2.1.4 Anti-infectives
  • 1.2.2 by Application
    • 1.2.2.1 Prostate Cancer
    • 1.2.2.2 Ovarian Cancer
    • 1.2.2.3 Bladder Cancer
    • 1.2.2.4 Cervical Cancer
    • 1.2.2.5 Renal Cancer
    • 1.2.2.6 Erectile Dysfunction
    • 1.2.2.7 Urinary Tract Infections
    • 1.2.2.8 Urinary Incontinence & Overactive Bladder
    • 1.2.2.9 Sexually Transmitted Diseases
    • 1.2.2.10 Interstitial Cystitis
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Urologicals Market, 2013-2018
  • 4.1.2 Hormonal Therapy Market, 2013-2018
  • 4.1.3 Gynecological Market, 2013-2018
  • 4.1.4 Anti-infectives Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Urologicals Market Forecast, 2019-2024
  • 4.2.2 Hormonal Therapy Market Forecast, 2019-2024
  • 4.2.3 Gynecological Market Forecast, 2019-2024
  • 4.2.4 Anti-infectives Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Prostate Cancer Market, 2013-2018
  • 5.1.2 Ovarian Cancer Market, 2013-2018
  • 5.1.3 Bladder Cancer Market, 2013-2018
  • 5.1.4 Cervical Cancer Market, 2013-2018
  • 5.1.5 Renal Cancer Market, 2013-2018
  • 5.1.6 Erectile Dysfunction Market, 2013-2018
  • 5.1.7 Urinary Tract Infections Market, 2013-2018
  • 5.1.8 Urinary Incontinence & Overactive Bladder Market, 2013-2018
  • 5.1.9 Sexually Transmitted Diseases Market, 2013-2018
  • 5.1.10 Interstitial Cystitis Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Prostate Cancer Market Forecast, 2019-2024
  • 5.2.2 Ovarian Cancer Market Forecast, 2019-2024
  • 5.2.3 Bladder Cancer Market Forecast, 2019-2024
  • 5.2.4 Cervical Cancer Market Forecast, 2019-2024
  • 5.2.5 Renal Cancer Market Forecast, 2019-2024
  • 5.2.6 Erectile Dysfunction Market Forecast, 2019-2024
  • 5.2.7 Urinary Tract Infections Market Forecast, 2019-2024
  • 5.2.8 Urinary Incontinence & Overactive Bladder Market Forecast, 2019-2024
  • 5.2.9 Sexually Transmitted Diseases Market Forecast, 2019-2024
  • 5.2.10 Interstitial Cystitis Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Novartis AG
• 8.2 Genentech

9 Conclusion

Summary
The global Genitourinary Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Urologicals
Hormonal Therapy
Gynecological
Anti-infectives
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Novartis AG
Genentech
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cervical Cancer
Renal Cancer
Erectile Dysfunction
Urinary Tract Infections
Urinary Incontinence & Overactive Bladder
Sexually Transmitted Diseases
Interstitial Cystitis
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa